High Normal Urinary Albumin–Creatinine Ratio Is Associated With Hypertension, Type 2 Diabetes Mellitus, HTN With T2DM, Dyslipidemia, and Cardiovascular Diseases in the Chinese Population: A Report From the REACTION Study

Background Albuminuria has been widely considered a risk factor for cardiovascular diseases (CVDs), which is associated with hypertension (HTN), type 2 diabetes mellitus (T2DM), HTN with T2DM, and dyslipidemia. However, the associations between albuminuria and HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs are still unclear. Thus, this study aimed to explore the association of albuminuria thoroughly, especially within the normal range, with the abovementioned diseases in the Chinese population. Methods This study included 40,188 participants aged over 40 years from seven centers across China. Urinary albumin–creatinine ratio (UACR) was firstly divided into the ≥30-mg/g group, indicating kidney damage, and <30-mg/g group. Furthermore, UACR was divided into five groups: the <20%, 20%–39%, 40%–59%, 60%–79%, and ≥80% groups, according to the quintile division of participants within the normal range. Propensity score matching was used to reduce bias, and multiple logistic regression models were conducted to examine the association between UACR and HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs. Results Multivariable regression analysis revealed that UACR, even within the normal range, is significantly associated with HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs, and the association between UACR and HTN with T2DM was the most significant in model 3 even after adjusting for confounding factors (HTN: OR = 1.56 (95% CI = 1.45–1.68), p < 0.0001; T2DM: OR = 1.78 (95% CI = 1.60–1.97), p < 0.0001; HTN with T2DM: OR = 1.76 (95% CI = 1.59–1.95), p < 0.0001; dyslipidemia: OR = 1.08 (95% CI = 1.01–1.14), p = 0.0146; CVDs: OR = 1.12 (95% CI = 1.00–1.25), p = 0.0475). In the stratified analysis, high normal UACR was significantly associated with HTN, T2DM, HTN with T2DM, and dyslipidemia in subgroups. Conclusions In summary, we observe a higher prevalence of HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs in abnormal UACR and reveal a significant association of UACR, even within the normal range, with HTN, T2DM, HTN with T2DM, dyslipidemia, and CVDs.

[1]  Q. Wan,et al.  Association of lipid accumulation product with chronic kidney disease in Chinese community adults: a report from the REACTION study , 2021, Lipids in Health and Disease.

[2]  Weiqing Wang,et al.  Elevated triglycerides rather than other lipid parameters are associated with increased urinary albumin to creatinine ratio in the general population of China: a report from the REACTION study , 2019, Cardiovascular Diabetology.

[3]  K. Ohashi,et al.  Nonproteinuric Versus Proteinuric Phenotypes in Diabetic Kidney Disease: A Propensity Score–Matched Analysis of a Nationwide, Biopsy-Based Cohort Study , 2019, Diabetes Care.

[4]  Xiaoxi Zhang,et al.  Oxidative stress-mediated influence of plasma DPP4 activity to BDNF ratio on mild cognitive impairment in elderly type 2 diabetic patients: results from the GDMD study in China. , 2018, Metabolism: clinical and experimental.

[5]  Jian-fei Song,et al.  Triglyceride-mediated influence of serum angiopoietin-like protein 8 on subclinical atherosclerosis in type 2 diabetic patients: results from the GDMD study in China , 2018, Cardiovascular Diabetology.

[6]  P. Dagnelie,et al.  Microvascular endothelial dysfunction is associated with albuminuria: the Maastricht Study , 2018, Journal of hypertension.

[7]  E. Park,et al.  Differential Association of Vitamin D Deficiency With Albuminuria by Sex in the Korean General Population: A Cross-sectional Study of the Korea National Health and Nutrition Examination Survey 2011-2012 , 2018, Journal of preventive medicine and public health = Yebang Uihakhoe chi.

[8]  M. Marre,et al.  Relationship between cardiac microvascular dysfunction measured with 82Rubidium-PET and albuminuria in patients with diabetes mellitus , 2018, Cardiovascular Diabetology.

[9]  A. Hirayama,et al.  Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study , 2017, Cardiovascular Diabetology.

[10]  Jennifer K. Sun,et al.  Association of Glycemic Control With Reduced Risk for Large-Vessel Disease After More Than 50 Years of Type 1 Diabetes , 2017, The Journal of clinical endocrinology and metabolism.

[11]  Min Kyung Kim,et al.  Relationship between the triglyceride glucose index and coronary artery calcification in Korean adults , 2017, Cardiovascular Diabetology.

[12]  T. Lüscher,et al.  Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. , 2017, The American journal of medicine.

[13]  A. Hoes,et al.  2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. , 2016, European heart journal.

[14]  K. Ogasawara,et al.  Low-grade albuminuria and incidence of cardiovascular disease and all-cause mortality in nondiabetic and normotensive individuals , 2016, Journal of hypertension.

[15]  H. Hong,et al.  Urinary albumin excretion within the normal range predicts the development of diabetes in Korean men. , 2015, Diabetes research and clinical practice.

[16]  M. Rewers,et al.  Plasma triglycerides predict incident albuminuria and progression of coronary artery calcification in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study. , 2014, Journal of clinical lipidology.

[17]  M. Woodward,et al.  Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data , 2014, The Lancet.

[18]  R. Kawasaki,et al.  Slight increase in urinary albumin excretion within the normal range predicts incident hypertension in a community-based Japanese population: the Takahata study , 2014, Hypertension Research.

[19]  D. de Zeeuw,et al.  Microalbuminuria: target for renoprotective therapy PRO. , 2014, Kidney international.

[20]  Zhen Ye,et al.  Cohort profile: Risk evaluation of cancers in Chinese diabetic individuals: a longitudinal (REACTION) study (队列简介:中国糖尿病患者肿瘤发生风险的纵向研究(REACTION研究)) , 2014, Journal of diabetes.

[21]  A. Levin,et al.  Practice Guideline , 2020, Encyclopedia of Behavioral Medicine.

[22]  G. Rossi Diagnosis and Classification of Diabetes Mellitus , 2012, Diabetes Care.

[23]  A. Levey,et al.  High normal levels of albuminuria and risk of hypertension in Indo-Asian population. , 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[24]  R. Collins,et al.  The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012, The Lancet.

[25]  G. Ning Risk Evaluation of cAncers in Chinese diabeTic Individuals: A lONgitudinal (REACTION) study , 2012, Journal of diabetes.

[26]  B. Nordestgaard,et al.  LCAT, HDL cholesterol and ischemic cardiovascular disease: a Mendelian randomization study of HDL cholesterol in 54,500 individuals. , 2012, The Journal of clinical endocrinology and metabolism.

[27]  B. Nordestgaard,et al.  Abstract 16452: LCAT, HDL Cholesterol and Myocardial Infarction - A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals , 2011 .

[28]  A. Abdelhafiz,et al.  Microalbuminuria: Marker or Maker of Cardiovascular Disease , 2011, Nephron Experimental Nephrology.

[29]  Patrick J Heagerty,et al.  Temporal trends in the prevalence of diabetic kidney disease in the United States. , 2011, JAMA.

[30]  Pedagógia,et al.  Cross Sectional Study , 2019 .

[31]  R. Heine,et al.  HbA1c and mean blood glucose show stronger associations with cardiovascular disease risk factors than do postprandial glycaemia or glucose variability in persons with diabetes: the A1C-Derived Average Glucose (ADAG) study , 2010, Diabetologia.

[32]  M. Woodward,et al.  Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis , 2010, The Lancet.

[33]  M. Rewers,et al.  Serum uric acid levels predict the development of albuminuria over 6 years in patients with type 1 diabetes: findings from the Coronary Artery Calcification in Type 1 Diabetes study. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[34]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[35]  D. de Zeeuw,et al.  Screening for albuminuria identifies individuals at increased renal risk. , 2009, Journal of the American Society of Nephrology : JASN.

[36]  G. Curhan,et al.  Higher levels of albuminuria within the normal range predict incident hypertension. , 2008, Journal of the American Society of Nephrology : JASN.

[37]  R. Stan,et al.  Resolved: capillary endothelium is a major contributor to the glomerular filtration barrier. , 2007, Journal of the American Society of Nephrology : JASN.

[38]  W. Knowler,et al.  Albuminuria within the "normal" range and risk of cardiovascular disease and death in American Indians: the Strong Heart Study. , 2007, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[39]  S. Grundy,et al.  Reduction of low-density lipoprotein cholesterol in patients with coronary heart disease and metabolic syndrome: analysis of the Treating to New Targets study , 2006, The Lancet.

[40]  D. Levy,et al.  Low-Grade Albuminuria and Incidence of Cardiovascular Disease Events in Nonhypertensive and Nondiabetic Individuals: The Framingham Heart Study , 2005, Circulation.

[41]  D. Levy,et al.  Low-Grade Albuminuria and the Risks of Hypertension and Blood Pressure Progression , 2005, Circulation.

[42]  M. G. Modena,et al.  Flow-mediated vasodilation and the risk of developing hypertension in healthy postmenopausal women. , 2004, Journal of the American College of Cardiology.

[43]  N. Day,et al.  Microalbuminuria independently predicts all-cause and cardiovascular mortality in a British population: The European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study. , 2004, International journal of epidemiology.

[44]  N. Day,et al.  Microalbuminuria and stroke in a British population: the European Prospective Investigation into Cancer in Norfolk (EPIC‐Norfolk) population study , 2004, Journal of internal medicine.

[45]  Lee Hebert,et al.  Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[46]  Daniel W. Jones,et al.  The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.

[47]  M. D. Di Carli,et al.  Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. , 2003, Journal of the American College of Cardiology.

[48]  K. Kohnert,et al.  Peripheral arterial disease in diabetes mellitus type 1 and type 2: are there different risk factors? , 2002, VASA. Zeitschrift fur Gefasskrankheiten.

[49]  Hans L Hillege,et al.  Urinary Albumin Excretion Predicts Cardiovascular and Noncardiovascular Mortality in General Population , 2002, Circulation.

[50]  J. Coresh,et al.  Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[51]  S. Yusuf,et al.  Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. , 2001, JAMA.

[52]  L. Bouter,et al.  Microalbuminuria and peripheral arterial disease are independent predictors of cardiovascular and all-cause mortality, especially among hypertensive subjects: five-year follow-up of the Hoorn Study. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[53]  M. Omata,et al.  Reduced myocardial flow reserve in non-insulin-dependent diabetes mellitus. , 1997, Journal of the American College of Cardiology.

[54]  J. Chambers,et al.  Microalbuminuria as a marker of silent myocardial ischaemia in IDDM patients. , 1996, Diabetologia.

[55]  K. Borch-Johnsen,et al.  Albuminuria reflects widespread vascular damage , 1989, Diabetologia.

[56]  P. Wilson,et al.  Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. , 1986, JAMA.

[57]  K. Maurer,et al.  Third national health and nutrition examination survey , 1985 .

[58]  P. Whelton,et al.  Hypertension , 1942, Nature Reviews Disease Primers.

[59]  T. Lüscher,et al.  Cardiovascular Protection in the Treatment of Type 2 Diabetes: A Review of Clinical Trial Results Across Drug Classes. , 2017, The American journal of cardiology.

[60]  Elisa T. Lee,et al.  The Strong Heart Study , 2015 .

[61]  Kyungdo Han,et al.  Relationship between dyslipidemia and albuminuria in prediabetic adults: The Korea National Health and Nutrition Examination Survey 2011–2012 , 2014, Endocrine.

[62]  Cholesterol Treatment Trialists' Collaborato The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials , 2012 .

[63]  P. Toth LCAT, HDL Cholesterol and Ischemic Cardiovascular Disease: A Mendelian Randomization Study of HDL Cholesterol in 54,500 Individuals , 2012 .

[64]  W. Brown Framingham Heart Study. , 2011, Journal of clinical lipidology.

[65]  M. Taskinen,et al.  [ESC/EAS Guidelines for the management of dyslipidaemias]. , 2011, Revista espanola de cardiologia.

[66]  D. de Zeeuw,et al.  Urinary albumin excretion as a predictor of the development of hypertension in the general population. , 2006, Journal of the American Society of Nephrology : JASN.

[67]  N. Yoshiike,et al.  A 15.5-year follow-up study of stroke in a Japanese provincial city. The Shibata Study. , 1997, Stroke.

[68]  TetsujiYokoyama,et al.  A 15.5-Year Follow-up Study of Stroke in a Japanese Provincial City , 1997 .